In September 2024, Leuven, Belgium was host to the fifth international ILC Symposium. More than 150 researchers, clinicians and individuals who have had or are
This year Memorial Sloan Kettering launched a new Lobular Breast Cancer Program! This new program focusing on improving treatment for patients with lobular breast cancer
After a year of discussion with LBCA, the U.S. Center for Disease Control and Prevention (CDC) has updated the breast cancer page on its website
As part of Breast Cancer Awareness month, LBCA is shining a spotlight on the 15% of breast cancer diagnoses each year that are invasive lobular
The first Global Lobular Breast Cancer Awareness Day is less than 2 months away on Oct. 15th! Help us declare this awareness day for Lobular
Click Here to Read the Global Declaration Letter The Lobular Breast Cancer Alliance (LBCA), a US nonprofit organization whose mission is to raise awareness and
LBCA Declares October 15th Global Lobular Breast Cancer Awareness Day Read More »
October is Breast Cancer Awareness Month, and there is still such a huge need to make everyone aware of invasive lobular carcinoma (ILC), its troubling
LBCA Board Runs and Remembers Deb Mueller Read More »
In August 2023, Jason Mouabbi, MD, assumed the role of chair of the Lobular Breast Cancer Alliance (LBCA) Scientific Advisory Board (SAB). Dr. Mouabbi is
LBCA Welcomes Dr. Jason Mouabbi As New Scientific Advisory Board Chair Read More »
The Lobular Breast Cancer Alliance (LBCA) is excited to announce Capucine Héraud, PhD, as the recipient of the 2023 AACR-LBCA Invasive Lobular Carcinoma (ILC) Research
Capucine Héraud, PhD, Awarded 2023 AACR-LBCA ILC Research Fellowship Read More »
The Lobular Breast Cancer Alliance Inc. is conducting a survey of individuals diagnosed with invasive lobular carcinoma (ILC) and their experiences with breast surgery. You
Take LBCA’s Survey About ILC & Breast Surgery Read More »
A Letter from Our Executive Director May is National Cancer Research Month and a great time to highlight some of the recently published studies focusing
Highlighting Lobular Breast Cancer Research Read More »
Name of Trial/NCT#: LobularCard: Â NCT05410951 Summary: With this project we will aim to identify the frequency of 113 germline variants in lobular breast cancer patients.
LobularCard: Searching for Novel Germline Mutations in ILC Patients Read More »
Lobular Breast Cancer Alliance (LBCA) Scientific Advisory Board members Dr. Jason Mouabbi and Dr. Gary Ulaner were part of the recent process of the Society
LBCA Scientists Discuss Appropriate Use Criteria for FES/PET Read More »
Deborah (Deb) Lynn Mueller, MD, of San Antonio, Texas, wife, mother of two teenage daughters, prominent Trauma Surgeon and Critical Care Physician at UT Health
Remembering LBCA Board Member Dr. Deb Mueller Read More »
Last week the Lobular Breast Cancer Alliance (LBCA) released its Fiscal Year 2022 Annual Report, which features highlights of our accomplishments between July 1, 2021
LBCA Accomplishments So Far in FY23 (since July 2022) Read More »
"*" indicates required fields
